Cargando…
Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
As the third leading cause of cancer death worldwide, hepatocellular carcinoma (HCC) is characterized by late detection, difficult diagnosis and treatment, rapid progression, and poor prognosis. Current treatments for liver cancer include surgical resection, radiofrequency ablation, liver transplant...
Autores principales: | Liu, Ruiqi, Li, Hong, Qiu, Yihua, Liu, Hongguang, Cheng, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694760/ https://www.ncbi.nlm.nih.gov/pubmed/36355512 http://dx.doi.org/10.3390/ph15111339 |
Ejemplares similares
-
Radionuclide therapy of hepatocellular carcinoma
por: Sundram, FX
Publicado: (2006) -
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
por: Lee, Edward Wolfgang, et al.
Publicado: (2017) -
Circular RNAs in hepatocellular carcinoma: Recent advances
por: Niu, Zhao-Shan, et al.
Publicado: (2022) -
Recent advances in recurrent hepatocellular carcinoma therapy
por: Gao, Yu-Xue, et al.
Publicado: (2023) -
Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)